We are live on ! Find out more
LONA

LeonaBio Inc

50 hedge funds and large institutions have $5.3M invested in LeonaBio Inc in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

6% more capital invested

Capital invested by funds: $5M → $5.3M (+$293K)

0% less ownership

Funds ownership: 4.5%4.49% (-0%)

6% less funds holding

Funds holding: 5350 (-3)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
50
Holders Change
-3
Holders Change %
-5.66%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
11
Reduced
6
Closed
8
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
+$4K

LONA Hedge Fund Activity: Q2 2025 in Review

50 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q2 2025, worth a combined $5.3M — up 5.9% from $5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of LONA and 6 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 11 added.

The largest buyer was Citadel Advisors, adding an estimated $45.5K. The largest seller was Bristlecone Advisors, exiting entirely with an estimated $71.9K sold.

  • 50 institutional investors held LeonaBio Inc (LONA) as of Q2 2025, down from 53 in Q1 2025.
  • Funds reported $5.3M of LeonaBio Inc stock for Q2 2025, up 5.9% quarter-over-quarter.
  • 6 funds opened new LeonaBio Inc positions in Q2 2025 and 8 closed out, a net change of -2 holders.
  • The largest LeonaBio Inc buyer in Q2 2025 was Citadel Advisors, an estimated $45.5K added.
  • The largest LeonaBio Inc seller in Q2 2025 was Bristlecone Advisors, an estimated $71.9K sold.

Based on aggregated 13F filings for Q2 2025.